(Q38043974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Christopher P Fox

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Lindsay C George

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

Current hematologic malignancy reports

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

276-284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22983913%20AND%20SRC:MED&resulttype=core&format=json

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus: 40 years on

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Evidence for early infection of nonneoplastic natural killer cells by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

CD56 (NKH1)-positive hematolymphoid malignancies: an aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Consistent patterns of allelic loss in natural killer cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Loss of Epstein-Barr virus-encoded RNA expression in cutaneous dissemination of natural killer/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

EBV viral load in tumor tissue is an important prognostic indicator for nasal NK/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK/T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Antisense oligodeoxynucleotides to latent membrane protein 1 induce growth inhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

The latent membrane protein 2 gene of Epstein-Barr virus is important for efficient B cell immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Roles of small RNAs in tumor formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

The pathological roles of BART miRNAs in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Prevalence of epstein‐barr virus DNA in different T‐cell lymphoma entities in a European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Absence of Epstein-Barr virus in anaplastic large cell lymphoma: a study of 64 cases classified according to World Health Organization criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11899-012-0136-Z

Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type

21 January 2018

1 reference

12 December 2020

Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1 reference

12 December 2020

Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma

1 reference

12 December 2020

Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies

1 reference

12 December 2020

Observations ON MALIGNANT GRANULOMA OF THE NOSE

1 reference

12 December 2020

A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type

1 reference

12 December 2020

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

1 reference

12 December 2020

Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: the neoplastic cells are often CD3 epsilon+

1 reference

12 December 2020

Expression of adult and fetal natural killer cell markers in sinonasal lymphomas

1 reference

12 December 2020

Nasal T-cell lymphoma as a type of so-called "lethal midline granuloma"

1 reference

12 December 2020

Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection

1 reference

12 December 2020

Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.

1 reference

12 December 2020

1 reference

12 December 2020

A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas

1 reference

12 December 2020

Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years

1 reference

12 December 2020

Epstein-Barr virus in a CD8-positive T-cell lymphoma

1 reference

12 December 2020

Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia

1 reference

12 December 2020

Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract.

1 reference

12 December 2020

Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus

1 reference

12 December 2020

Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.

1 reference

12 December 2020

Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis

1 reference

12 December 2020

The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

1 reference

12 December 2020

Photographs of a case of rapid destruction of the nose and face. 1897.

1 reference

12 December 2020

Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma

1 reference

12 December 2020

Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies

1 reference

12 December 2020